Increasing interoperability for research clouds: CS3APIs for connecting sync&share storage, applications and science environments

Autor: González Labrador Hugo, Mościcki Jakub T., Lamanna Massimo, Pace Alberto

Publikováno v: EPJ Web of Conferences, Vol 245, p 07041 (2020)

Cloud Services for Synchronization and Sharing (CS3) [14] have become increasing popular in the European Education and Research landscape in the last years. Services such as CERNBox, SWITCHdrive, SURFdrive, PSNCBox, Sciebo, CloudStor and many more ha

Externí odkaz: https://doaj.org/article/6aca1462310e47e5bc86a681d364a9f7

Differential effect of atorvastatin and tacrolimus on proliferation of vascular smooth muscle and endothelial cells

Autor: Arturo Giordano, Nicola Corcione, Paolo Ferraro, Simona Romano, Antonio Sorrentino, Anna Laura Di Pace, Mario Monaco, Michele Polimeno, Maria Fiammetta Romano, Giovanna Nappo

Publikováno v: American Journal of Physiology-Heart and Circulatory Physiology. 302:H135-H142

Although considered promising for use in drug-eluting stents (DES), tacrolimus failed clinically. Tacrolimus inhibits growth factor production but can also act as a growth factor on vascular smooth muscle cells (VSMC). This unexpected proliferative s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3650d9f19708908cf459c677973b8242
https://doi.org/10.1152/ajpheart.00490.2011

Iron-Catalyzed Cross-Electrophile Coupling for the Formation of All-Carbon Quaternary Centers.

Autor: Pace AL; Merck Center for Catalysis at Princeton University, Princeton, New Jersey 08544, United States., Xu F; Merck Center for Catalysis at Princeton University, Princeton, New Jersey 08544, United States., Liu W; Merck Center for Catalysis at Princeton University, Princeton, New Jersey 08544, United States., Lavagnino MN; Merck Center for Catalysis at Princeton University, Princeton, New Jersey 08544, United States., MacMillan DWC; Merck Center for Catalysis at Princeton University, Princeton, New Jersey 08544, United States.

Publikováno v: Journal of the American Chemical Society [J Am Chem Soc] 2024 Dec 04; Vol. 146 (48), pp. 32925-32932. Date of Electronic Publication: 2024 Nov 20.

The selective prolyl hydroxylase inhibitor IOX5 stabilizes HIF-1α and compromises development and progression of acute myeloid leukemia.

Autor: Lawson H; The Institute of Cancer Research, London, UK.; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Holt-Martyn JP; Chemistry Research Laboratory, Department of Chemistry and the Ineos Oxford Institute for Antimicrobial Research, University of Oxford, Oxford, UK., Dembitz V; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Department of Physiology and Immunology and Croatian Institute for Brain Research, University of Zagreb School of Medicine, Zagreb, Croatia., Kabayama Y; Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, UK., Wang LM; The Institute of Cancer Research, London, UK.; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Bellani A; The Institute of Cancer Research, London, UK.; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Atwal S; Chemistry Research Laboratory, Department of Chemistry and the Ineos Oxford Institute for Antimicrobial Research, University of Oxford, Oxford, UK., Saffoon N; Chemistry Research Laboratory, Department of Chemistry and the Ineos Oxford Institute for Antimicrobial Research, University of Oxford, Oxford, UK., Durko J; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., van de Lagemaat LN; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, UK., De Pace AL; Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, UK., Tumber A; Chemistry Research Laboratory, Department of Chemistry and the Ineos Oxford Institute for Antimicrobial Research, University of Oxford, Oxford, UK., Corner T; Chemistry Research Laboratory, Department of Chemistry and the Ineos Oxford Institute for Antimicrobial Research, University of Oxford, Oxford, UK., Salah E; Chemistry Research Laboratory, Department of Chemistry and the Ineos Oxford Institute for Antimicrobial Research, University of Oxford, Oxford, UK., Arndt C; Chemistry Research Laboratory, Department of Chemistry and the Ineos Oxford Institute for Antimicrobial Research, University of Oxford, Oxford, UK., Brewitz L; Chemistry Research Laboratory, Department of Chemistry and the Ineos Oxford Institute for Antimicrobial Research, University of Oxford, Oxford, UK., Bowen M; Chemistry Research Laboratory, Department of Chemistry and the Ineos Oxford Institute for Antimicrobial Research, University of Oxford, Oxford, UK., Dubusse L; The Institute of Cancer Research, London, UK.; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., George D; The Institute of Cancer Research, London, UK.; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Allen L; The Institute of Cancer Research, London, UK.; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Guitart AV; Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, UK.; Université de Bordeaux, Institut National de la Santé et de la Recherche Médicale INSERM U1035, Bordeaux, France., Fung TK; Leukemia and Stem Cell Biology Group, Comprehensive Cancer Centre, King's College London, London, UK.; Department of Haematological Medicine, King's College Hospital, King's College London, London, UK., So CWE; Leukemia and Stem Cell Biology Group, Comprehensive Cancer Centre, King's College London, London, UK.; Department of Haematological Medicine, King's College Hospital, King's College London, London, UK., Schwaller J; University Children's Hospital Basel (UKBB), Department of Biomedicine, University of Basel, Basel, Switzerland., Gallipoli P; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., O'Carroll D; Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, UK., Schofield CJ; Chemistry Research Laboratory, Department of Chemistry and the Ineos Oxford Institute for Antimicrobial Research, University of Oxford, Oxford, UK. christopher.schofield@chem.ox.ac.uk., Kranc KR; The Institute of Cancer Research, London, UK. kamil.kranc@icr.ac.uk.; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK. kamil.kranc@icr.ac.uk.

Publikováno v: Nature cancer [Nat Cancer] 2024 Jun; Vol. 5 (6), pp. 916-937. Date of Electronic Publication: 2024 Apr 18.

MicroRNA analysis of Natural Killer cell-derived exosomes: the microRNA let-7b-5p is enriched in exosomes and participates in their anti-tumor effects against pancreatic cancer cells.

Autor: Di Pace AL; Tumor Immunology Unit, Bambino Gesù Children's Hospital, Rome, Italy., Pelosi A; Tumor Immunology Unit, Bambino Gesù Children's Hospital, Rome, Italy., Fiore PF; Tumor Immunology Unit, Bambino Gesù Children's Hospital, Rome, Italy., Tumino N; Immunology Research Area, Innate Lymphoid Cells Unit, Bambino Gesù Children's Hospital, Rome, Italy., Besi F; Tumor Immunology Unit, Bambino Gesù Children's Hospital, Rome, Italy., Quatrini L; Tumor Immunology Unit, Bambino Gesù Children's Hospital, Rome, Italy., Santopolo S; Tumor Immunology Unit, Bambino Gesù Children's Hospital, Rome, Italy., Vacca P; Immunology Research Area, Innate Lymphoid Cells Unit, Bambino Gesù Children's Hospital, Rome, Italy., Moretta L; Tumor Immunology Unit, Bambino Gesù Children's Hospital, Rome, Italy.

Publikováno v: Oncoimmunology [Oncoimmunology] 2023 Jun 07; Vol. 12 (1), pp. 2221081. Date of Electronic Publication: 2023 Jun 07 (Print Publication: 2023).